Phase-I of the Covid-19 vaccination strategy was launched on January 16, 2021, where priority was accorded to health care workers and frontline workers.
Phase-II was initiated from March 1, 2021, which focused on protecting the most vulnerable. This included people above 45 years of age who account for more than 80 per cent of Covid mortality in the country.
The key highlights of Phase 3 include:
* Vaccine manufacturers would supply 50% of their monthly stock to the Centre and would be free to supply the remaining doses to state governments and in the open market.
Phase-I of the Covid-19 vaccination strategy was launched on January 16, 2021, where priority was accorded to health care workers and frontline workers.
Phase-II was initiated from March 1, 2021, which focused on protecting the most vulnerable. This included people above 45 years of age who account for more than 80 per cent of Covid mortality in the country.
The key highlights of Phase 3 include:
* Vaccine manufacturers would supply 50% of their monthly stock to the Centre and would be free to supply the remaining doses to state governments and in the open market.